Xylose

   
Google
 
Web NewDrugInformation.com

Xylose


Drug - Xylose
The trade name of the product as shown on the labeling.

Dosage - POWDER; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Xylose
Multiple ingredients are in alphabetical order.

Strength - 25GM/BOT
The potency of the active ingredient(s), Xylose. May repeat for multiple part products.

Applicant - LYNE
The firm name holding legal responsibility for Xylose. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018856
The FDA assigned number to Xylose. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Xylose. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 26, 1987
The date Xylose was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Xylose. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Xylose is in. Format is RX, OTC, DISCN.

Applicant Full Name - Lyne Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Xylose.

Xylose